Get the Weekly Intelligence Brief — top committee picks every Sunday.

SPB vs UTI

Spectrum Brands Holdings, Inc. vs Universal Technical Institute, Inc. — AI-powered side-by-side comparison
SPB
Spectrum Brands Holdings, Inc.
66
Buy
VS
UTI
Universal Technical Institute, Inc.
53
Watch
MetricSPBUTI
AI Score 66 53
Price $88.15 $25.56
P/E Ratio 26.40× 40.60×
ROE 5.2% 19.2%
Revenue Growth YoY
Gross Margin 39.8% 61.5%
Debt / Equity 0.06× 1.04×
Dividend Yield 2.1% 0.0%
RSI (14) 46.9 20.6
Beta 0.646 1.236
Expected Upside

AI Committee View

Current Innellis committee reasoning for SPB versus UTI.
SPB leads by 13 points.

SPB scores 66/100 (Buy) versus UTI at 53/100 (Watch).

SPB Committee View
83% agreement
6 analysts

The primary driver is vix regime is low -- calm backdrop supports risk-taking. The main limiting factor is revenue declining -3.8% yoy -- this is not a growth story right now. The committee is constructive but not yet at full conviction.

Bull Case
  • Price-to-book of 0.7x is a discount to asset value — Value
  • EPS growing 150.6% YoY — Growth
  • Price structure making higher highs and higher lows — Technical
Bear Case
  • Revenue declining -3.8% YoY -- this is not a growth story right now — Growth
  • MACD histogram negative -- bearish momentum — Technical
UTI Committee View
67% agreement
6 analysts

The committee is genuinely divided. Macro Analyst sees a compelling case — vix regime is low -- calm backdrop supports risk-taking. Technical Analyst remains cautious — rsi at 21 is in oversold territory (could mean either capitulation or a bounce setup). This disagreement is itself the signal — the setup is not clean in either direction.

Bull Case
  • Low leverage (debt-to-equity 0.27) -- balance sheet can absorb a shock — Risk
  • VIX regime is low -- calm backdrop supports risk-taking — Macro
  • Market regime is bullish (Bull market -- normal position sizing) — Macro
Bear Case
  • P/E of 37.4 is moderate-to-rich — Value
  • Price-to-book of 5.4x prices in significant intangible value — Value
  • EPS declining -25.9% YoY despite any revenue growth — Growth
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
SPB Full Analysis UTI Full Analysis